Onglyza
Product Images NDC 54868-6309

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Onglyza (NDC 54868-6309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Onglyza 5 mg Bottle Label (6309)

Onglyza 5 mg Bottle Label (6309)
ONGLYZA tablet bottle label from Physicians Total Care, Inc. showing NDC 54868-6309-0 with a quantity of 30 tablets. The label includes lot number 0000 and an expiration date of January 2060. The manufacturing information and a barcode are also visible on the label.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph illustrating the mean change from baseline in A1C (%) over 24 weeks for three groups: ONGLYZA 2.5 mg + Metformin, ONGLYZA 5 mg + Metformin, and Placebo + Metformin. The x-axis shows weeks from baseline to 24, and the y-axis indicates A1C percentage change, with error bars shown at week 24 (LOCF). The graph depicts that both ONGLYZA doses combined with Metformin reduce A1C levels more than placebo combined with Metformin over time.*
FDA Label Image

Saxagliptin Chemical Structure (Saxagliptin Struct)

Saxagliptin Chemical Structure (Saxagliptin Struct)
Chemical structure diagram of the active ingredient in ONGLYZA, showing a bicyclic molecular framework with an amide, amino, hydroxyl groups, a nitrile, and a water molecule (H2O) associated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.